FINWIRES · TerminalLIVE
FINWIRES

交易所交易基金涨跌互现,美国股市午后上涨

-- 市场整体指标 综合市场交易所交易基金(ETF)IWM走软,而IVV上涨。活跃交易的景顺QQQ信托基金(QQQ)上涨0.5%。 周四午后,美国股指走高,此前以色列和黎巴嫩同意停火10天,扫清了延长伊朗停火协议外交谈判的障碍。 能源板块 iShares美国能源ETF(IYE)和道富能源精选行业SPDR基金(XLE)均上涨约1.6%。 科技板块 道富科技精选行业SPDR基金(XLK)上涨0.9%;iShares美国科技ETF(IYW)上涨0.7%;iShares扩展科技行业ETF(IGM)上涨0.8%。 道富SPDR标普半导体基金(XSD)上涨2%,iShares半导体基金(SOXX)上涨0.9%。 金融 道富金融精选行业SPDR基金(XLF)下跌0.1%。Direxion每日3倍做多金融基金(FAS)下跌0.4%,其对应的做空基金Direxion每日3倍做空金融基金(FAZ)上涨0.3%。 大宗商品 原油下跌0.8%,美国石油基金(USO)上涨3.8%。天然气上涨1.3%,美国天然气基金(UNG)上涨1.2%。 纽约商品交易所黄金下跌0.2%,道富SPDR黄金基金(GLD)下跌0.1%。白银下跌1.2%,iShares白银信托基金(SLV)下跌1%。 消费板块 道富消费必需品精选行业SPDR基金(XLP)上涨0.2%。先锋消费必需品ETF(VDC)上涨0.1%,iShares道琼斯美国消费品ETF(IYK)上涨0.2%。 道富非必需消费品精选行业SPDR基金(XLY)下跌0.4%。VanEck零售ETF(RTH)持平,而道富SPDR标普零售ETF(XRT)上涨0.8%。 医疗保健板块 道富医疗保健精选行业SPDR基金(XLV)下跌0.7%,iShares美国医疗保健ETF(IYH)下跌0.8%,先锋医疗保健ETF(VHT)下跌0.7%。iShares生物技术ETF(IBB)下跌0.9%。 工业板块 道富工业精选行业SPDR基金(XLI)下跌0.5%。先锋工业指数基金 (VIS) 和 iShares 美国工业指数基金 (IYJ) 也出现下跌。 加密货币 午盘交易中,比特币 (BTC-USD) 下跌 0.9%。在加密货币 ETF 中,ProShares 比特币 ETF (BITO) 下跌 1%,ProShares 以太坊 ETF (EETH) 下跌 1.7%,ProShares 比特币和以太坊市值加权 ETF (BETH) 下跌 0.9%。

Related Articles

Asia

Oneview Healthcare Reports Decline in Q1 Cash Receipts From Customers; Shares Up 3%

Oneview Healthcare (ASX:ONE) reported cash receipts from customers of about 3.3 million euros for the first quarter, compared with 4.2 million euros a year earlier, according to a Monday filing with the Australian bourse.The company noted that the year-ago figure includes two large customer receipts totaling more than 2 million euros, which were due to be received during the fourth quarter of 2024 but were received in early 2025.Oneview Healthcare ended March with a cash balance of AU$17.1 million, up from AU$8.1 million at the close of 2025, per the filing.The company's shares gained 3% in recent Monday trade.

$ASX:ONE
Asia

Paradigm to Advance Participants Through Day 112 Follow-Up Period in Phase Three Knee Osteoarthritis Trial, Shares Reach One-Year Low

Paradigm Biopharmaceuticals (ASX:PAR) is set to progress participants through the day 112 follow-up period for the phase three trial evaluating injectable pentosan polysulfate sodium for the treatment of pain associated with knee osteoarthritis in the June quarter, which is required for inclusion in the interim analysis dataset, according to a Monday Australian bourse filing.The independent statistical analysis results for the data set are expected around August. Timing remains subject to the scheduling and review processes of independent third parties, and there is a reasonable likelihood that final interim outcomes may extend into September, it cautioned.The interim analysis is expected to provide the first phase three evaluation of efficacy and safety for injectable pentosan polysulfate sodium in knee osteoarthritis. Primary endpoint top-line results are expected in the March 2027 quarter.Its shares fell 14% in recent trading on Monday, reaching their lowest point in over a year.

$ASX:PAR
Asia

Sanan Optoelectronics Q1 Profit Down 68%, Revenue Slides 33%

Sanan Optoelectronics (SHA:600703) posted first-quarter attributable net profit of 67.5 million yuan, down 68% from 211.9 million yuan the previous year.Earnings per share declined to 0.01 yuan from 0.04 yuan, according to a weekend filing with the Shanghai bourse.Operating revenue declined 33% year over year to 2.91 billion yuan from 4.31 billion yuan.Shares of the software company declined 2% in recent trade.

$SHA:600703